William Doran, DO
Orthopaedic Surgery · Millsboro, DENPI 1790070035
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (47.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Stryker at 43.2% of the total. Reporting peaked in 2019 at $5,377 and has fallen 82.0% since, to $967 in 2025.
Across 167 payments — averaging $80.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$6K
- Supreme Orthopedic Systems, LLC$5K
- Arthrex$2K
- Biocomposites Inc$96
- Johnson & Johnson$40
- Heron Therapeutics, Inc.$37
- plus $146 from 8 others
What the payments were for
- Travel & lodging$2,67520%
- Food & beverage$4,40133%
- Education$6,38747%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 132 | $5,818 |
| Supreme Orthopedic Systems, LLC | 7 | $5,000 |
| Arthrex | 15 | $2,325 |
| Biocomposites Inc | 1 | $96 |
| Johnson & Johnson | 2 | $40 |
| Heron Therapeutics, Inc. | 2 | $37 |
| KCI USA, Inc. | 1 | $31 |
| Abbott | 1 | $24 |
| Bioventus LLC | 1 | $21 |
| Dynasplint Systems Inc. | 1 | $17 |
| Sanara Medtech Inc. | 1 | $16 |
| DJO, LLC | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Smith+Nephew | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,463 in reported general payments places this provider in the 70th percentile of 70 orthopaedic surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 13 | $142 |
| Methylprednisolone | 22 | $128 |
| Oxycodone Hcl | 18 | $98 |
| Meloxicam | 12 | $75 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $58 |
| Tramadol Hcl | 15 | $57 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Millsboro
- Michal KlekMillsboro$7K
- Courtney CaputoMillsboro$1K
- Suken ShahWilmington$2.1M
- Jeremie AxeNewark$179K
- Andrew CurleySeaford$70K
- Patrick WardWilmington$68K
- Patrick KaneLewes$68K
- Kenneth LingenfelterNewark$67K
- Drew BradyNewark$64K
- Steven DelloseWilmington$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.